REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Rigvir SIA (Latvia)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Medicinal and Botanical Manufacturing | Biological Product (except Diagnostic) Manufacturing | Medical and Diagnostic Laboratories
Full name: Rigvir SIA Profile Updated: December 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Rigvir SIA is an enterprise based in Latvia. Its main office is in Riga. The company operates in the Pharmaceutical Preparation Manufacturing sector. The enterprise was incorporated on February 27, 2014. The total number of employees is currently 4 (2023). During that time, Rigvir SIA’s total assets decreased by 0.12%.

Headquarters
Atlasa iela 7C
Riga; Riga; Postal Code: 1026

Contact Details: Purchase the Rigvir SIA report to view the information.

Basic Information
Total Employees:
Purchase the Rigvir SIA report to view the information.
Registered Capital:
Purchase the Rigvir SIA report to view the information.
Financial Auditors:
Purchase the Rigvir SIA report to view the information.
Incorporation Date:
February 27, 2014
Key Executives
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
65.58%
Purchase this report to view the information.
21.24%
Purchase this report to view the information.
5.12%
Purchase this report to view the information.
2.78%
Purchase this report to view the information.
2.78%
Subsidiaries
Latima SIA
93.36%
Company Performance
Financial values in the chart are available after Rigvir SIA report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Total operating revenue
-97.22%▼
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
-24.51%▼
Total Assets
-0.12%▼
Total Equity
-1.75%▼
Return on Equity (ROE)
-0.37%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo